Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change

Published:2020-09 Issue:4 Volume:35 Page:824-834
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:J Eur Acad Dermatol Venereol

Author:

Nogueira M.¹,Warren R.B.²,Torres T.¹³^ORCID

Affiliation:

1. Department of Dermatology Centro Hospitalar Universitário do Porto Porto Portugal

2. The Dermatology Centre Salford Royal NHS Foundation Trust Manchester NIHR Biomedical Research Centre The University of Manchester Manchester UK

3. Instituto de Ciências Biomédicas Abel Salazar University of Porto Porto Portugal

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.16866

Reference74 articles.

2. Psoriasis Pathogenesis and Treatment

3. The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

4. Opportunistic Infections in Biological Therapy, Risk and Prevention

5. Infectious Complications of Biologic Agents

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risankizumab efficacy and safety in psoriatic patients with latent tuberculosis infection: A multicentric real‐world study;Journal of the European Academy of Dermatology and Venereology;2024-09-13

2. Risk for latent tuberculosis infection reactivation among patients with psoriasis on biologics treatment: A meta-analysis;Journal of Infection;2024-09

3. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus;Journal of the European Academy of Dermatology and Venereology;2024-08-16

4. Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review;Dermatology and Therapy;2024-07-16

5. How useful is chest X-ray in addition to routine QuantiFERON® in the detection of latent tuberculosis prior to biologics?;Clinical and Experimental Dermatology;2024-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3